Abstract

To identify factors that affect manifestations of sickle cell anemia we compared patients 11-30 years of age from University of Ibadan, Ibadan, Oyo, Nigeria (n = 214) and University of Illinois at Chicago, Chicago, IL, USA (n = 209). Paralleling findings in the general populations of the two countries, the Chicago patients were more often overweight or obese as defined by the Centers for Disease Control and Prevention (Atlanta, GA, USA) guidelines, and more often had elevated blood pressure (BP) as defined by the National Heart, Lung, and Blood Institute (NHLBI), Bethesda, MD, USA guidelines. The Ibadan patients did not receive the pneumococcal vaccine or hydroxyurea (HU) therapy as frequently as the Chicago patients. Consistent with lower rates of elevated BP and increased body mass index (BMI), stroke history was less frequent in the Ibadan patients ≥18 years old. Furthermore, in combined analyses, systolic and diastolic BP directly correlated with BMI, and elevated weight status independently associated with history of stroke. Our findings are consistent with the possibility that higher values for BMI and BP in Chicago sickle cell anemia patients may contribute to an increased risk of stroke and highlights the need for measures to reduce these risk factors. On the other hand, lower pneumococcal vaccination and HU therapy rates in Ibadan patients highlights the need for more improved vaccination coverage and for studies to define the role of HU therapy in Africa.

MeSH

Cells, Hemoglobins, Hypertension, Stroke, Vaccines, Anemia, Sickle Cell, Anemia, Vaccination, Centers For Disease Control And Prevention, U.S., Risk Factors, Therapeutics, History

Cited by

• Vitamin D levels are low in adult patients with sickle cell disease in Jamaica and West Africa. BMC Hematol, 2014
• Neurologic complications of sickle cell disease in Africa: A systematic review and meta-analysis. Neurology, 2017
• Clinical characteristics and risk factors of relative systemic hypertension and hypertension among sickle cell patients in Cameroon. Front Med (Lausanne), 2022
• Rates and risk factors of hypertension in adolescents and adults with sickle cell anaemia in Tanzania: 10 years' experience. Br J Haematol, 2017
• Similar burden of type 2 diabetes among adult patients with sickle cell disease relative to African Americans in the U.S. population: a six-year population-based cohort analysis. Br J Haematol, 2020
• Gaps in knowledge about the vaccine coverage of immunocompromised children: a scoping review. Hum Vaccin Immunother, 2022
• An Analysis of Racial and Ethnic Backgrounds Within the CASiRe International Cohort of Sickle Cell Disease Patients: Implications for Disease Phenotype and Clinical Research. J Racial Ethn Health Disparities, 2021
• Predictors of hospital readmissions in adult patients with sickle cell disease. Am J Blood Res, 2024
• Incident Stroke in Pediatric Sickle Cell Anemia Despite Overall Improved Transcranial Doppler Velocity in a Ugandan Hydroxyurea Trial: Antecedent and Ongoing Risks. Pediatr Blood Cancer, 2025
• Genetics of Sickle Cell-Associated Cardiovascular Disease: An Expert Review with Lessons Learned in Africa. OMICS, 2017
• Paediatric immunisation and chemoprophylaxis in a Ugandan sickle cell disease clinic. J Paediatr Child Health, 2020
• Factors associated with blood pressure variation in sickle cell disease patients: a systematic review and meta-analyses. Expert Rev Hematol, 2022
• Prevalence of relative systemic hypertension in adults with sickle cell disease in Ghana. PLoS One, 2018
• Prescription audit in a paediatric sickle cell clinic in South-West Nigeria: A cross-sectional retrospective study. Malawi Med J, 2018
• Characterising the prevalence of overweight and obese status among adults with sickle cell disease. Br J Haematol, 2023
• Nutritional perspectives on sickle cell disease in Africa: a systematic review. BMC Nutr, 2021
• Epidemiology of Stroke in Sickle Cell Disease. J Clin Med, 2021